1. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives
   Meenu Mehta et al, 2021, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
2. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation
   Chao Wu et al, 2019, Journal of Ethnopharmacology CrossRef
3. Decreased microRNA‑768‑3p expression indicates a poor prognosis in patients with breast cancer and promotes breast cancer cell viability, migration and invasion
   Yanhua Zhou et al, 2021, Oncology Letters CrossRef
4. Non-coding RNAs: a promising target for early metastasis intervention
   Yi Xiao et al, 2023, Chinese Medical Journal CrossRef
5. The role of cancer-derived microRNAs in cancer immune escape
   Ming Yi et al, 2020, Journal of Hematology & Oncology CrossRef
6. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism
   Chunyu Cao et al, 2020, Clinical and Experimental Medicine CrossRef
7. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models
   Giuseppe Murdaca et al, 2019, International Journal of Molecular Sciences CrossRef
8. MicroRNA-671-3p inhibits the development of breast cancer: A study based on in vitro experiments, in-house quantitative polymerase chain reaction and bioinformatics analysis
   Dan-Dan Xiong et al, 2018, International Journal of Oncology CrossRef
9. Transcriptomic analysis reveals tumor stage- or grade-dependent expression of miRNAs in serous ovarian cancer
   Caglar Berkel et al, 2021, Human Cell CrossRef
10. microRNA‑574 inhibits cell proliferation and invasion in glioblastoma multiforme by directly targeting zinc finger E‑box‑binding homeobox 1
    Youyan Mao et al, 2018, Molecular Medicine Reports CrossRef